Lahiru Handunnetthi

4.6k total citations · 4 hit papers
41 papers, 2.9k citations indexed

About

Lahiru Handunnetthi is a scholar working on Pathology and Forensic Medicine, Immunology and Molecular Biology. According to data from OpenAlex, Lahiru Handunnetthi has authored 41 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 18 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Lahiru Handunnetthi's work include Multiple Sclerosis Research Studies (13 papers), T-cell and B-cell Immunology (7 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Lahiru Handunnetthi is often cited by papers focused on Multiple Sclerosis Research Studies (13 papers), T-cell and B-cell Immunology (7 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Lahiru Handunnetthi collaborates with scholars based in United Kingdom, Canada and United States. Lahiru Handunnetthi's co-authors include Sreeram V Ramagopalan, George C. Ebers, Adam E. Handel, Giulio Disanto, Julian C. Knight, Gavin Giovannoni, Matthew R. Lincoln, Sarah-Michelle Orton, Narelle Maugeri and Julia M. Morahan and has published in prestigious journals such as Circulation, Nature Medicine and Nature Communications.

In The Last Decade

Lahiru Handunnetthi

40 papers receiving 2.8k citations

Hit Papers

A ChIP-seq defined genome... 2010 2026 2015 2020 2010 2021 2021 2022 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lahiru Handunnetthi United Kingdom 20 1.4k 661 610 441 410 41 2.9k
Johann Sellner Germany 32 1.6k 1.1× 620 0.9× 444 0.7× 444 1.0× 1.4k 3.3× 172 3.8k
Cheryl Hemingway United Kingdom 31 1.5k 1.1× 378 0.6× 686 1.1× 402 0.9× 1.7k 4.2× 91 3.8k
Michael J. Olek United States 22 2.2k 1.7× 940 1.4× 170 0.3× 275 0.6× 410 1.0× 38 3.2k
Melinda Magyari Denmark 35 2.7k 2.0× 559 0.8× 164 0.3× 323 0.7× 865 2.1× 181 3.6k
Rune Midgard Norway 30 1.7k 1.2× 403 0.6× 245 0.4× 227 0.5× 602 1.5× 66 2.4k
Trygve Holmøy Norway 36 2.3k 1.7× 1.2k 1.9× 169 0.3× 515 1.2× 788 1.9× 170 3.8k
Marianna Cortese United States 18 948 0.7× 427 0.6× 168 0.3× 368 0.8× 378 0.9× 44 2.1k
Terry A. McNearney United States 33 1.3k 0.9× 702 1.1× 237 0.4× 586 1.3× 53 0.1× 79 3.4k
Paulo Louzada‐Júnior Brazil 32 284 0.2× 911 1.4× 136 0.2× 720 1.6× 155 0.4× 152 3.1k
Robert G. Lahita United States 33 492 0.4× 1.6k 2.4× 154 0.3× 447 1.0× 129 0.3× 85 4.0k

Countries citing papers authored by Lahiru Handunnetthi

Since Specialization
Citations

This map shows the geographic impact of Lahiru Handunnetthi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lahiru Handunnetthi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lahiru Handunnetthi more than expected).

Fields of papers citing papers by Lahiru Handunnetthi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lahiru Handunnetthi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lahiru Handunnetthi. The network helps show where Lahiru Handunnetthi may publish in the future.

Co-authorship network of co-authors of Lahiru Handunnetthi

This figure shows the co-authorship network connecting the top 25 collaborators of Lahiru Handunnetthi. A scholar is included among the top collaborators of Lahiru Handunnetthi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lahiru Handunnetthi. Lahiru Handunnetthi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grant, Eleanor, Andrew G. Murchison, Sophie Binks, et al.. (2024). Magnetic Resonance Imaging Characteristics of LGI1-Antibody and CASPR2-Antibody Encephalitis. JAMA Neurology. 81(5). 525–525. 8 indexed citations
2.
Handunnetthi, Lahiru, Maheshi Ramasamy, Lance Turtle, & David Hunt. (2024). Identifying and reducing risks of neurological complications associated with vaccination. Nature Reviews Neurology. 20(9). 541–554.
3.
Holt, Gregory, et al.. (2023). Stem-cell derived neurosphere assay highlights the effects of viral infection on human cortical development. Brain Behavior and Immunity. 115. 718–726. 1 indexed citations
4.
Jeffery, Katie, Paul Klenerman, Ming Lim, et al.. (2023). The immunobiology of herpes simplex virus encephalitis and post-viral autoimmunity. Brain. 147(4). 1130–1148. 17 indexed citations
5.
Patone, Martina, Xue W. Mei, Lahiru Handunnetthi, et al.. (2022). Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex. Circulation. 146(10). 743–754. 125 indexed citations breakdown →
6.
Saatci, Defne, et al.. (2022). Maternal immune activation induces methylation changes in schizophrenia genes. PLoS ONE. 17(11). e0278155–e0278155. 6 indexed citations
7.
Pokhilko, Alexandra, Lahiru Handunnetthi, Raphael Heilig, et al.. (2021). Global proteomic analysis of extracellular matrix in mouse and human brain highlights relevance to cerebrovascular disease. Journal of Cerebral Blood Flow & Metabolism. 41(9). 2423–2438. 19 indexed citations
8.
Patone, Martina, Lahiru Handunnetthi, Defne Saatci, et al.. (2021). Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nature Medicine. 27(12). 2144–2153. 246 indexed citations breakdown →
9.
Elangovan, Ramyiadarsini, Giulio Disanto, Antonio J. Berlanga‐Taylor, Sreeram V Ramagopalan, & Lahiru Handunnetthi. (2014). Regulatory genomic regions active in immune cell types explain a large proportion of the genetic risk of multiple sclerosis. Journal of Human Genetics. 59(4). 211–215. 5 indexed citations
10.
Ramagopalan, Sreeram V, Andrew Skingsley, Lahiru Handunnetthi, et al.. (2014). Data set of primary outcome changes in interventional clinical trials registered on ClinicalTrials.org. London School of Hygiene & Tropical Medicine. 1 indexed citations
11.
Handel, Adam E., Geir Kjetil Sandve, Giulio Disanto, et al.. (2013). Integrating multiple oestrogen receptor alpha ChIP studies: overlap with disease susceptibility regions, DNase I hypersensitivity peaks and gene expression. BMC Medical Genomics. 6(1). 45–45. 5 indexed citations
12.
Watson, Corey T., Matthew R. Lincoln, S. V. Ramagopalan, et al.. (2011). Revisiting the T-cell receptor alpha/delta locus and possible associations with multiple sclerosis. Genes and Immunity. 12(2). 59–66. 6 indexed citations
13.
Ramagopalan, S V, Lahiru Handunnetthi, Matthew R. Lincoln, et al.. (2010). Vitamin-D Receptor and 1-alpha-hydroxylase Genes in Risk and Outcome of Multiple Sclerosis in Canadians. Multiple Sclerosis Journal. 16. 271–271. 1 indexed citations
14.
Disanto, Giulio, et al.. (2010). The emerging role of vitamin D binding protein in multiple sclerosis. Journal of Neurology. 258(3). 353–358. 36 indexed citations
15.
Handel, Adam E., et al.. (2010). An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis. PLoS ONE. 5(9). e12496–e12496. 249 indexed citations
16.
Ramagopalan, Sreeram V., Jake Byrnes, David A. Dyment, et al.. (2009). Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis. Journal of Human Genetics. 54(9). 547–549. 16 indexed citations
17.
Ward, Hamish E., Katie Morrison, S. V. Ramagopalan, et al.. (2009). Risk alleles for multiple sclerosis in multiplex families. Neurology. 72(23). 1984–1988. 50 indexed citations
18.
Ramagopalan, Sreeram V., Katie Morrison, Adam E. Handel, et al.. (2009). Variants in ST8SIA1 do not play a major role in susceptibility to multiple sclerosis in Canadian families. Journal of Neuroimmunology. 212(1-2). 142–144. 1 indexed citations
19.
Ebers, George C., S V Ramagopalan, Narelle Maugeri, et al.. (2008). Expression of the multiple sclerosis associated MHC class II allele HLA-DRBI*1501 is regulated by vitamin D. Annals of Neurology. 64. 2 indexed citations
20.
Ramagopalan, Sreeram V., David A. Dyment, Katie Morrison, et al.. (2008). Methylation of class II transactivator gene promoter IV is not associated with susceptibility to Multiple Sclerosis. BMC Medical Genetics. 9(1). 63–63. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026